BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Massironi S, Zilli A, Conte D. Somatostatin analogs for gastric carcinoids: For many, but not all. World J Gastroenterol 2015; 21(22): 6785-6793 [PMID: 26078554 DOI: 10.3748/wjg.v21.i22.6785]
URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6785.htm
Number Citing Articles
1
A. V. Alekberzade, N. N. Krylov, E. M. Lipnitskiy, R. O. Shakhbazov, F. Azari. Gastric neuroendocrine tumorsKhirurgiya. Zhurnal im. N.I. Pirogova 2019; (12): 111 doi: 10.17116/hirurgia2019121111
2
Roberta Modica, Luigi Camera, Vincenzo Napolitano, Manuela Avellino, Rosa Fonti, Silvana Del Vecchio, Leonardo De Luca, Annamaria Colao, Antongiulio Faggiano. Neuroendocrine Tumors in Real Life2018; : 171 doi: 10.1007/978-3-319-59024-0_11
3
Shozo Sasaki, Toru Kurata, Shigeta Hagino, Yasuhiro Shoji, Itsuro Terada, Akemi Yoshikawa, Hirohisa Kitagawa, Takashi Fujimura, Ryohei Izumi, Katsuhiko Saito. Peritoneal Metastasis Detected 16 Years after Primary Operation for Gastric Neuroendocrine TumorThe Japanese Journal of Gastroenterological Surgery 2018; 51(8): 520 doi: 10.5833/jjgs.2017.0176
4
Hui-Fang Zhang, Yi Zheng, Xue Wen, Jing Zhao, Jun Li. Gastric neuroendocrine tumors in a <i>BRCA2</i> germline mutation carrier: A case reportWorld Journal of Gastrointestinal Oncology 2023; 15(8): 1497-1504 doi: 10.4251/wjgo.v15.i8.1497
5
玉娇 吴. Research Progress in Gastric Neuroendocrine TumorsAdvances in Clinical Medicine 2024; 14(05): 1329 doi: 10.12677/acm.2024.1451557
6
Sinju Sundaresan, Anthony J Kang, Michael M Hayes, Eun-Young K Choi, Juanita L Merchant. Deletion ofMen1andsomatostatininduces hypergastrinemia and gastric carcinoidsGut 2017; 66(6): 1012 doi: 10.1136/gutjnl-2015-310928
7
Oriol Calvete, Andrea Varro, D. Mark Pritchard, Alicia Barroso, Marta Oteo, Miguel Ángel Morcillo, Pierfrancesco Vargiu, Steven Dodd, Miriam Garcia, José Reyes, Sagrario Ortega, Javier Benitez. A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategiesDisease Models & Mechanisms 2016; 9(9): 975 doi: 10.1242/dmm.025890
8
Yuichi Sato, Satoru Hashimoto, Ken-ichi Mizuno, Manabu Takeuchi, Shuji Terai. Management of gastric and duodenal neuroendocrine tumorsWorld Journal of Gastroenterology 2016; 22(30): 6817-6828 doi: 10.3748/wjg.v22.i30.6817
9
Brian Furman. Reference Module in Biomedical Sciences2018;  doi: 10.1016/B978-0-12-801238-3.97143-5
10
Fernando Sebastian-Valles, Blanca Bernaldo Madrid, Carolina Sager, Elena Carrillo López, Sara Mera Carreiro, Laura Ávila Antón, Noelia Sánchez-Maroto García, Miguel Antonio Sampedro-Nuñez, Jose Ángel Díaz Pérez, Mónica Marazuela. Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine TumorsBiomedicines 2023; 11(3): 872 doi: 10.3390/biomedicines11030872
11
Britney Corey, Herbert Chen. Neuroendocrine Tumors of the StomachSurgical Clinics of North America 2017; 97(2): 333 doi: 10.1016/j.suc.2016.11.008
12
Chuyan Chen, Yi Yang, Peng Li, Haiyi Hu. Incidence of Gastric Neoplasms Arising from Autoimmune Metaplastic Atrophic Gastritis: A Systematic Review and Case ReportsJournal of Clinical Medicine 2023; 12(3): 1062 doi: 10.3390/jcm12031062